Armata Pharmaceuticals (ARMP) Return on Sales [ROS] (2013 - 2020)
Armata Pharmaceuticals (ARMP) posted Return on Sales [ROS] of -14806.45% for Q2 2020.
Powered by 
Analysis
Armata Pharmaceuticals (ARMP) Return on Sales [ROS] (2013 - 2020) Analysis & Trends
For the trailing twelve months through Jun 30, 2020, Return on Sales [ROS] at Armata Pharmaceuticals was -17661.54%; for FY2017, it came in at -14048.70%, down 5057.16 percentage points from FY2016.
- Annual Return on Sales [ROS] shows a four-year change of +1240.19 percentage points (FY2013 to FY2017).
- In prior years, Armata Pharmaceuticals' Return on Sales [ROS] was -8991.54% in FY2016 (-6838.49 pp), -2153.05% in FY2015 (+1296.83 pp), -3449.88% in FY2014 (+11839.01 pp) and -15288.89% in FY2013.
- The Q2 2020 figure stands as the highest quarterly Return on Sales [ROS] since Q4 2017.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2017, with a gain of 42102.27 percentage points; the weakest was Q4 2016, with a drop of 51630.40 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Armata Pharmaceuticals | 130.01 Mn | 77.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | -14,806.45% |
| Dec 31, 2017 | -11,825.00% |
| Sep 30, 2017 | -1,963.16% |
| Jun 30, 2017 | -34,592.86% |
| Mar 31, 2017 | -11,582.76% |
| Dec 31, 2016 | -53,927.27% |
| Sep 30, 2016 | -11,748.28% |
| Jun 30, 2016 | -3,484.47% |
| Mar 31, 2016 | -4,262.26% |
| Dec 31, 2015 | -2,296.88% |
| Sep 30, 2015 | -1,697.90% |
| Jun 30, 2015 | -2,541.18% |
| Mar 31, 2015 | -2,222.55% |
| Dec 31, 2014 | -2,571.29% |
| Sep 30, 2014 | -5,078.64% |
| Jun 30, 2014 | -3,710.89% |
| Mar 31, 2014 | -2,436.54% |
| Dec 31, 2013 | -14,234.48% |
| Sep 30, 2013 | -78,033.33% |
| Jun 30, 2013 | -1,950.32% |
API Access
Armata Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ARMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();